CD44 and breast cancer: Next, we investigated other potential determinants of TNBC aggressiveness exploring the self-renewal capability of the mammosphere-forming MDA-MB-231 cells, which are acknowledged to exhibit certain features associated with mammary cancer stem cells (CSCs) like the CD44+/high/CD24−/low phenotype [35].